Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus.
Miajlovic
Helen
H
Moyne Institute of Preventive Medicine, Trinity College, Dublin, Ireland.
Fallon
Padraic G
PG
Irvine
Alan D
AD
Foster
Timothy J
TJ
D018829:Adhesins, Bacterial / Q000235:genetics / Q000378:metabolism; D048708:Cell Growth Processes; D003030:Coagulase / Q000235:genetics / Q000378:metabolism; D003876:Dermatitis, Atopic / Q000235:genetics* / Q000276:immunology / Q000382:microbiology; D000091344:Filaggrin Proteins; D006801:Humans; D006863:Hydrogen-Ion Concentration; D057131:Immune Evasion; D007381:Intermediate Filament Proteins / Q000235:genetics / Q000378:metabolism*; D009154:Mutation / Q000235:genetics; D011761:Pyrrolidonecarboxylic Acid / Q000378:metabolism*; D013205:Staphylococcal Protein A / Q000235:genetics / Q000378:metabolism; D013211:Staphylococcus aureus / Q000502:physiology*; D013234:Stem Cells; D014560:Urocanic Acid / Q000378:metabolism*
D018829:Adhesins, Bacterial; D003030:Coagulase; C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D007381:Intermediate Filament Proteins; D013205:Staphylococcal Protein A; C078635:fibronectin-binding proteins, bacterial; D014560:Urocanic Acid; D011761:Pyrrolidonecarboxylic Acid